Inhibitors of membranous adenylyl cyclases with affinity for adenosine receptors.
about
Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer modelA2A adenosine receptor antagonists to weaken the hypoxia-HIF-1α driven immunosuppression and improve immunotherapies of cancer.International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
P2860
Inhibitors of membranous adenylyl cyclases with affinity for adenosine receptors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Inhibitors of membranous adenylyl cyclases with affinity for adenosine receptors.
@en
Inhibitors of membranous adenylyl cyclases with affinity for adenosine receptors.
@nl
type
label
Inhibitors of membranous adenylyl cyclases with affinity for adenosine receptors.
@en
Inhibitors of membranous adenylyl cyclases with affinity for adenosine receptors.
@nl
prefLabel
Inhibitors of membranous adenylyl cyclases with affinity for adenosine receptors.
@en
Inhibitors of membranous adenylyl cyclases with affinity for adenosine receptors.
@nl
P2860
P1476
Inhibitors of membranous adenylyl cyclases with affinity for adenosine receptors.
@en
P2093
Sonja Kachler
P2860
P2888
P304
P356
10.1007/S00210-015-1197-Z
P577
2015-12-14T00:00:00Z